Southeast Asia is a high-potential market for the overseas expansion of aesthetic medical devices. While the regulatory systems of countries in the region align with the unified ASEAN framework, they also retain local detailed requirements. The choice of compliance pathway directly determines market entry efficiency and costs. This issue focuses on two core markets, Indonesia and Singapore, to break down the key registration rules and practical experience for high-risk aesthetic medical devices.
Risk classification is the prerequisite for registration
Before initiating registration, the product risk level must be determined in strict accordance with the official classification regulation Pedoman Klasifikasi. The classification result directly determines the registration pathway, and classification deviations will lead to direct rejection of application materials, delaying the overall project schedule.
Document certification is a mandatory threshold
The Free Sales Certificate (FSC) and Letter of Authorization (LOA) must obtain Apostille certification as required to be legally valid within Indonesia; uncertified documents will be directly rejected by the regulatory authority. If the product has obtained US FDA 510(k) clearance, a Certificate of Free Sale (CFG) issued in New York, USA may be used to replace the FSC, which is also officially recognized by the Indonesian MOH.
Strict control over localization and certificate information
Product instructions for use and labels must be fully translated into Indonesian to meet regulatory localization requirements. Meanwhile, information such as intended use, technical parameters, product description, labels and packaging illustrations will be directly presented in the final certificate as annexes. All information must be verified one by one before submission to avoid information discrepancies that could affect certificate validity and subsequent market launch.
Simplified pathway available with reference country certificates
Holding a registration certificate from a major mature market allows applicants to match the corresponding simplified registration pathway based on the actual situation of the product, effectively shortening the approval cycle and reducing compliance costs. This is the preferred solution for high-risk aesthetic medical devices entering the Singapore market.
Product configuration submission must align with regulatory logic
The product configuration list should not be organized solely based on internal enterprise logic. It must combine the product’s own characteristics while complying with HSA’s registration submission specifications and classification logic, to avoid additional information requests caused by configuration descriptions that do not meet regulatory standards, which would prolong the registration cycle.
As the largest medical device market in Latin America with the most sophisticated regulatory system, Brazil is a core target for Chinese medical device enterprises expanding into the South American market. To celebrate Wiselink’s 6th anniversary, we are launching a limited-time offer: from June 18 to July 18, a 20% discount applies to consulting service fees for medical device products of all risk classes in the Brazilian market. We welcome inquiries from new and existing clients.
